Ethanol: Clinical Trials

32 trials of Ethanol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

32 completed. 32 Phase 3, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 332Completed 32
Phase 24Completed 4

Follow Ethanol: new trials by email Literature Review of Ethanol trials Research Report on Ethanol

Trials (filtered) newest first · largest first

All 32 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Mouthwash in Reducing the Symptoms Associated With Flu and Cold Viruses
cetylpyridinium chloride (0.075%) and zinc alcohol free mouthwash - Healthy
Phase 3CompletedColgate Palmolive1502022-06-052026-10-07
Efficacy and Safety of Ethanol Inhalation on COVID-19 Treatment (a Clinical Trial Study)
Ethanol, Water Distilled - Clinical Infection, Outcome
Phase 3CompletedAli Amoushahi1502021-09-022022-04-25
Perioperative Patient Skin Antiseptic Preparation Evaluation
70% v/v Isopropyl Alcohol Surgical Solution, 2%w/v Chlorhexidine Gluconate / 70% v/v Isopropyl Alcohol - Surgical Site Infection
Phase 3CompletedZurex Pharma, Inc.512021-06-212024-03-20
Topical Cetirizine in Androgenetic Alopecia in Females
Topical cetirizine, Placebo, Topical minoxidil - Androgenetic Alopecia
Phase 2 / Phase 3CompletedCairo University662020-07-252023-02-08
The Effect of Lidocaine and Benzocaine on Pain and Injection Satisfaction in Peripheral Intravenous Catheter Application
Lidocaine Spray, Benzokain Sprey, Alcohol - Peripheral Intravenous Catheterization Application
Phase 3CompletedTC Erciyes University1202020-03-042021-04-26
In-vivo Efficacy of Patient Preoperative Prep, ZuraPrep (ZP)
ZuraPrep Clear Solution, ChloraPrep, ZuraPrep Vehicle - Surgical Skin Preparation
Phase 3CompletedZurex Pharma, Inc.1562019-01-252023-02-08
Vaginal Preparation With Chlorhexidine-alcohol vs. Povidine-iodine vs. Saline
Chlorhexidine-alcohol, Povidine-iodine, Sterile saline - Cesarean Section; Infection, Surgical Site Infection
Phase 2 / Phase 3CompletedColumbia University302018-10-012020-06-09
Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor
Sodium Oxybate - Spasmodic Dysphonia, Voice Tremor
Phase 2 / Phase 3CompletedKristina Simonyan1172018-01-222025-12-30
Clinical Evaluation of Patient Preoperative Prep
ZuraPrep, ChloraPrep, ZP Vehicle - Surgical Skin Preparation
Phase 3CompletedZurex Pharma, Inc.6402016-08-032021-07-16
In-vivo Efficacy of Patient Preoperative Prep
ZuraPrep, ChloraPrep, ZP Vehicle - Surgical Skin Preparation
Phase 3CompletedZurex Pharma, Inc.4402016-07-272023-02-08
Ethanol-lock Therapy for the Prevention of Non-tunneled Catheter-related Infection in Pediatric Patients
Ethanol-lock - Infection, Catheter-Related, Central Line-associated Bloodstream Infection (CLABSI)
Phase 3CompletedInstituto Materno Infantil Prof. Fernando Figueira1202016-03-012019-11-01
Bioequivalence Study for Benzyl Alcohol Lotion 5%.
Benzyl Alcohol Lotion 5%, Ulesfia (benzyl alcohol lotion) 5%, Placebo - Head Lice
Phase 3CompletedAkorn, Inc.2392015-08-012021-01-27
Efficacy of Two Chlorhexidine Solutions to Control the Initial Subgingival Biofilm Formation
0.12% Clorhexidine with alcohol, placebo, 0.12% Clorhexidine without alcohol - Dental Plaque
Phase 3CompletedFederal University of Rio Grande do Sul352015-07-012016-01-14
Mouthwash With Chlorhexidine 0.12%/Ethyl Alcohol 7% Compared to Ethyl Alcohol 7%
chlorhexidine 0.12%/Ethyl alcohol 7%, Ethyl Alcohol 7%, Chlorhexidine 2%/Ethyl alcohol 7% - Neutropenia
Phase 3CompletedHospital Regional de Alta Especialidad del Bajio602015-04-012018-05-25
In Vivo Efficacy Study of Patient Preoperative Preps
3M CHG/IPA Prep C, 3M CHG/IPA Prep CH, ChloraPrep - Bacterial Reduction Post-product Application
Phase 3Completed3M7382014-07-012020-11-23
In-vivo Efficacy Study of Patient Pre-operative Preps
ChloraPrep Hi-Lite Orange, Normal saline, 3M CHG/IPA Prep Tint 10.5-mL - Bacterial Reduction on Skin Flora Post-product Application
Phase 3CompletedSolventum US LLC4262013-10-012024-10-02
Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation
Ethanol, Ablation - Ventricular Tachycardia, Atrial Fibrillation
Phase 3CompletedThe Methodist Hospital Research Institute3432013-10-012025-08-21
Ethanol Lock Therapy for Treatment and Secondary Prophylaxis of Central Line-Associated Bloodstream Infection
ethanol, heparin-saline placebo - Central Line-Associated Bloodstream Infection
Phase 3CompletedSt. Jude Children's Research Hospital952011-12-292017-11-13
Isopropyl Alcohol Against Chlorhexidine - Isopropyl Alcohol as Antiseptics to Prevent Hemoculture's Contamination
chlorhexidine in isopropyl alcohol, Isopropyl alcohol - Infectious Diseases
Phase 3CompletedUniversidad de Guanajuato11022011-06-012016-08-19
The CArdiovasCulAr Diabetes & Ethanol (CASCADE) Trial
alcohol - Diabetes, Prediabetes
Phase 3CompletedBen-Gurion University of the Negev2242010-06-012019-07-15

Showing 20 of 32. Sign in to see all of them.

Conditions studied

Heart Diseases (3)  ·  Hypertension (3)  ·  Surgical Wound Infection (3)  ·  Cardiovascular Diseases (2)  ·  Communicable Diseases (2)  ·  Infections (2)  ·  Vascular Diseases (2)  ·  Acute Kidney Injury (1)  ·  Alcohol Drinking (1)  ·  Alopecia (1)  ·  Atrial Fibrillation (1)  ·  Bacteremia (1)  ·  COVID-19 (1)  ·  Catheter-Related Infections (1)  ·  Cross Infection (1)

Sponsors

Zurex Pharma, Inc. (4)  ·  National Heart, Lung, and Blood Institute (NHLBI) (2)  ·  3M (1)  ·  Akorn, Inc. (1)  ·  Ali Amoushahi (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Baylor College of Medicine (1)  ·  Ben-Gurion University of the Negev (1)  ·  C. R. Bard (1)  ·  Cairo University (1)  ·  Colgate Palmolive (1)  ·  Columbia University (1)  ·  Erasmus Medical Center (1)  ·  Federal University of Rio Grande do Sul (1)  ·  Hospital Regional de Alta Especialidad del Bajio (1)

Countries

United States (17)  ·  Brazil (3)  ·  France (2)  ·  Mexico (2)  ·  Australia (1)  ·  Egypt (1)  ·  Iran (1)  ·  Netherlands (1)  ·  Turkey (Türkiye) (1)

Top investigators

Alejandro E. Macias, M. D. (1)  ·  Asokumar Buvanendran, MD (1)  ·  Bart JA Rijnders, MD, PhD (1)  ·  Bellisa C Lopes, Master (1)  ·  Bertrand Souweine, Pr (1)  ·  Craig A. Field, PhD (1)  ·  Daryl S Paulsen, PhD (1)  ·  Elham Moazam, Researcher (1)  ·  Elisabeth Rivera (1)  ·  Hanan Nada, PhD (1)  ·  Harish Lavu, MD (1)  ·  Ian F Burgess, M.Phil. (1)  ·  Jamie Miller, ADN (1)  ·  Jeremiah Stamler (1)  ·  Joseph P Hart, MD, FACS, DFSVS (1)

Results publications

PMID 32131912, PMID 12660125, PMID 16585662, PMID 19339405, PMID 20054046, PMID 20497980, PMID 20520776, PMID 22388536, PMID 23218847, PMID 23490572, PMID 24263324, PMID 25667135, PMID 25668557, PMID 26124071, PMID 26232779, PMID 26458258, PMID 27692023, PMID 29884572, PMID 31435005, PMID 32335895, PMID 33107945, PMID 33345865, PMID 34039478, PMID 35363884, PMID 35799302, PMID 36447221, PMID 36571611, PMID 37311720, PMID 40009628, PMID 41106729

NIH funding

R01AA015439 (1), R01DC012545 (1), R01HL021823 (1), R01HL024999 (1), R01HL115003 (1), U01HL060574 (1)